Sunitinib (SU) in combination with docetaxel (D) versus D alone for the first-line treatment of advanced breast cancer (ABC).
暂无分享,去创建一个
R. Greil | J. Bergh | K. Kern | A. Makhson | M. Lichinitser | J. Cortés | A. Lortholary | C. Giorgetti | X. Huang | N. Voytko | Alain Lortholary | Jorge E. Cortes | Xin Huang | J. Bergh | Nataliya L. Voytko